Key result
Disodium cromoglycate significantly reduced myocardial fibrosis and prevented infiltration and degranulation of mast cells in rats with postmyocarditis dilated cardiomyopathy.
Why the study?
Does disodium cromoglycate reduce myocardial fibrosis in a rat model of postmyocarditis dilated cardiomyopathy?
Does disodium cromoglycate reduce myocardial fibrosis in a rat model of postmyocarditis dilated cardiomyopathy?
Mast cell stabilization with disodium cromoglycate reduces myocardial fibrosis and mast cell infiltration in a rat model of postmyocarditis dilated cardiomyopathy, suggesting mast cells play a key role in its pathogenesis.
Answers are grounded in this paper and cite their sources.
Supports mast cell stabilization in fibrosis models; leaves open translation to human postmyocarditis dilated cardiomyopathy.
Dilated cardiomyopathy (DCM) is a major cause of morbidity and mortality. Occurrence of myocardial fibrosis is an important event in the ventricular remodeling process, which takes place during DCM. Mast cells are well known inflammatory cells implicated in various biological phenomena. The involvement of mast cells in the development of myocardial fibrosis of DCM in rats after autoimmune myocarditis remains unknown. Nine-week-old male Lewis rats were immunized with cardiac myosin and divided into vehicle treated (group V) and disodium cromoglycate (DSCG), a mast cell stabilizer (24 mg/kg i.p.) treated (group DSCG) groups. The animals were sacrificed after 60 d of immunization. The myocardium was excised and preserved for histopathology and protein analysis. Myocardial levels of transforming growth factor (TGF) beta1 and collagen-III were quantified. Staining of mast cells was performed by toluidine blue. A significant correlation was obtained between myocardial fibrosis and cardiac mast cell density. DSCG reduced myocardial fibrosis besides preventing infiltration and degranulation of mast cells. Our findings confirm the active participation of mast cells in the progression of myocardial fibrosis in rats with postmyocarditis DCM.
No takes yet. Share an insight, caveat, or question.
Selvaraj et al. (2005) studied Postmyocarditis Dilated Cardiomyopathy (n=40). Disodium cromoglycate (DSCG) vs. Saline (vehicle) was evaluated on Myocardial fibrosis area (p=<0.01). Disodium cromoglycate significantly reduced myocardial fibrosis and prevented infiltration and degranulation of mast cells in rats with postmyocarditis dilated cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: